Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer

Memorial Sloan Kettering Cancer Center · NCT06312124

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 45+ · Women only
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
266
US sites recruiting
9
Study start
March 8, 2024
Record last updated
June 24, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this study is to find out how many participants are interested in a surgical preventive procedure after watching an educational video. Before and after watching the video, participants will complete questionnaires in the clinic.

Being studied: Educational Module; Salpingectomy

Conditions: Surgery

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

Part I

  • Age ≥45 years
  • Scheduled visit with a nongynecologic surgeon
  • Female or assigned female at birth

Part II

  • Age ≥45 years
  • At least one in situ fallopian tube
  • No desire or plan to have children in the future
  • Average risk of developing ovarian cancer

° Note: Average risk patients are defined as patients with no known genetic risk factor for developing ovarian cancer. Patients who, after obtaining family history, are suspected to have a hereditary ovarian cancer syndrome but have not yet been tested, will be referred for genetic evaluation.

  • Planned nongynecologic, intraabdominal, or pelvic surgery
  • Deemed to be a suitable candidate by gynecologic surgeon and primary nongynecologic surgeon (for example, on the basis of surgical history and current malignancy status)
  • Approved and signed informed consent

Exclusion Criteria

Part I

  • Not fluent in English or Spanish

° If there is a non-english or non-spanish speaking participant who is a strong candidate and meets all other criteria for Part 2, they are able to go directly onto Part 2 without completing Part 1. (Please see additional details in section 4.1 and 7.0.)

  • Known inherited ovarian cancer susceptibility

Part II

  • Personal history of a gynecologic malignancy
  • Carrier of a hereditary breast or ovarian cancer variant (e.g., BRCA1, BRCA2, BRIP1, PALB2, RAD51C, RAD51D, MLH1, MSH2, MSH6, PMS2)
  • Suspicious ovarian, fallopian tube, or uterine lesion on preoperative imaging
  • Previous bilateral salpingectomy or bilateral salpingo-oophorectomy
  • Presence of ESSURE, or other tubal-implanted birth control at the time of surgery
  • Current pregnancy
  • Emergent procedure or emergency procedure that has to be completed within 24 hours where clinical consent occurs in the inpatient setting or where the patient's immediate well-being is in danger or condition may be life threatening
  • Primary surgeon anticipates that OS will add significant time (>30-40min) to the planned procedure.
  • Inability to access the pelvis (ex., patient prone/lateral position) during the planned procedure.
  • Known history of pelvic fibrosis or significant adhesions.
  • Procedures with palliative intent only

Recruiting US locations

  • Johns Hopkins University (Data Collection Only)

    Baltimore, MD 21287

    Site contact: Rebecca Stone, MD · 410-955-8240

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)

    Basking Ridge, NJ 07920

    Site contact: Kara Long Roche, MD · 646-608-3787

  • Memorial Sloan Kettering Monmouth (Limited protocol activities)

    Middletown, NJ 07748

    Site contact: Kara Long Roche, MD · 646-608-3787

  • Memorial Sloan Kettering Bergen (Limited Protocol Activities)

    Montvale, NJ 07645

    Site contact: Kara Long Roche, MD · 646-608-3787

  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities)

    Commack, NY 11725

    Site contact: Kara Long Roche, MD · 646-608-3787

  • Memorial Sloan Kettering Westchester (Limited Protocol Activities)

    Harrison, NY 10604

    Site contact: Kara Long Roche, MD · 646-608-3787

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)

    New York, NY 10065

    Site contact: Kara Long Roche, MD · 646-608-3787

  • Memorial Sloan Kettering Nassau (Limited Protocol Activities)

    Uniondale, NY 11553

    Site contact: Kara Long Roche, MD · 646-608-3787

  • MD Anderson Cancer Center (Data Collection Only)

    Houston, TX 77030

    Site contact: Larissa Meyer, MD · 713-792-6161

Study contacts (from the official record)

  • Kara Long Roche, MD · 212-639-7043 · longrock@mskcc.org
  • Martin Weiser, MD · 212-639-6698 · weiser1@mskcc.org
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer (NCT06312124) | Bored Studies